Cargando…
Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy
A liquid biopsy is a minimally invasive or non-invasive method to analyze a range of tumor material in blood or other body fluids, including circulating tumor cells (CTCs), cell-free DNA (cfDNA), messenger RNA (mRNA), microRNA (miRNA), and exosomes, which is a very promising technology. Among these...
Autores principales: | Liu, Shicai, Wang, Jinke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9222159/ https://www.ncbi.nlm.nih.gov/pubmed/35735625 http://dx.doi.org/10.3390/cimb44060184 |
Ejemplares similares
-
Liquid biopsy in cholangiocarcinoma: Current status and future perspectives
por: Rompianesi, Gianluca, et al.
Publicado: (2021) -
Liquid Biopsy: Current Status and Future Perspectives
por: Baev, Vesselin, et al.
Publicado: (2023) -
Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer
por: Mondelo-Macía, Patricia, et al.
Publicado: (2021) -
Liquid Biopsy in Prostate Cancer Management—Current Challenges and Future Perspectives
por: Crocetto, Felice, et al.
Publicado: (2022) -
Cell-Free DNA Fragmentomics in Liquid Biopsy
por: Ding, Spencer C., et al.
Publicado: (2022)